Efficacy and Safety of a Novel Plum Blossom Needling with Mild Moxibustion Device for Upper Limb Pain Disorder and Motor Dysfunction in Patients with Stage 1 Post-Stroke Shoulder-Hand Syndrome: Study Protocol for a Multi-Center, Single-Blind, Randomized Sham-Controlled Trial
Xiaonan Meng,Jie Sun,Qi Liu,Yueping Huang,Xianwen Qiu,David Jung Seto,Ying Li,Liping Wang,Chunying Li,Sen Gao,Haikuo Yu,Jiping Zhao,Baixiao Zhao
DOI: https://doi.org/10.2147/JPR.S396195
IF: 2.8319
2023-02-16
Journal of Pain Research
Abstract:Xiaonan Meng, 1, 2, &ast Jie Sun, 3, &ast Qi Liu, 4, &ast Yueping Huang, 5 Xianwen Qiu, 6 David Jung Seto, 7, 8 Ying Li, 3 Liping Wang, 2 Chunying Li, 2 Sen Gao, 9 Haikuo Yu, 10 Jiping Zhao, 1 Baixiao Zhao 1 1 Department of Acupuncture and Moxibustion, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Department of Acupuncture and Moxibustion, Beijing Huguosi TCM Hospital, Affiliated with Beijing University of Chinese Medicine, Beijing, People's Republic of China; 3 Department of Integrated Chinese and Western Medicine Rehabilitation, Beijing Xiaotangshan Hospital, Beijing, People's Republic of China; 4 Department of General Internal Medicine, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China; 5 School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 6 Department of Acupuncture and Moxibustion, Beijing Shichahai Community Healthcare Center, Beijing, People's Republic of China; 7 Division of Integrative Medicine, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA; 8 Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; 9 Department of Rehabilitation, Beijing Huguosi TCM Hospital, affiliated with Beijing University of Chinese Medicine, Beijing, People's Republic of China; 10 Rehabilitation Department, Xuanwu Hospital Capital Medical University, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jiping Zhao; Baixiao Zhao, Email ; Background: Post-stroke shoulder-hand syndrome (PS-SHS), a common neurological comorbidity after stroke episodes, poses a grave threat on patients' functional recovery. Preliminary trials have demonstrated that the acupuncture and moxibustion treatment, including a dermal acupuncture tapping method known as plum blossom needling (PBN) can improve pain and motor dysfunctions in patients with PS-SHS. However, there are few reports describing simultaneous moxibustion treatment in combination with PBN. Hence, a novel plum blossom needle device with mild moxibustion (PBNMM) was developed to evaluate its potential efficacy and safety in patients with stage 1 PS-SHS. Materials and Methods: This multicenter, sham-controlled, randomized controlled trial (RCT) will recruit 102 eligible patients with stage 1 PS-SHS from three clinical centers, randomly allocated in a ratio of 1:1:1 to the PBNMM group, PBNMM with no moxa smoke (PBNMM-NMS) group and sham control group. Patients in each group will receive a 30-minute treatment once per day for 4 weeks, with 5 consecutive sessions per week, for a total of 20 sessions. The primary outcome measure will be defined as the decreased scores from baseline in the visual analog scale (VAS) assessment at week 4. Secondary outcome measures will include scores on the Fugl-Meyer Assessment of the Upper Extremity Scale (FMA-UE), the Modified Barthel Index (MBI), and the somatosensory evoked potential (SEP) records. All outcomes will be evaluated at baseline and weeks 4, 5, 6 and 10, and the intention-to-treat analysis will be applied. Conclusion: This study aims to provide robust evidence for the efficacy and safety of the PBNMM for PS-SHS treatment, as well as the specific impact of moxibustion smoke itself in dealing with PS-SHS. Clinical Trial Registration: Chinese Clinical Trial Registry No. ChiCTR2200062441. Registered on 7 August 2022. Keywords: plum blossom needling, mild moxibustion, novel device, post-stroke shoulder-hand syndrome, protocol, randomized controlled trial Stroke, regarded as the top leading cause of death and disability, exerts heavy economic and social burdens worldwide. 1–3 Post-stroke shoulder-hand syndrome (PS-SHS), also known as post-stroke complex regional pain syndrome, was first observed by Oscar Stejnbroker, 4 and is experienced by up to 50% of stroke patients. 5 Stage 1 PS-SHS is usually characterized by the regional pain, spasticity, sympathetic dysfunction and motor impairment. 6–9 Of note, it is challenging for clinicians to prevent its progression from stage 1 to its end-stage presentation of irreversible joint degeneration and amyotrophy. 10 The current interventions for PS-SHS treatment vary a lot, including physical rehabilitation, pharmaceutical therapy and neuromodulation. -Abstract Truncated-
clinical neurology